In a recent study, researchers found that if started early enough, a daily regimen of the non-prescription NSAID ibuprofen can prevent Alzheimer’s disease.
This means that by taking an over-the-counter medication, people can ward off Alzheimer’s disease.
The study was done by a Vancouver-based research team.
According to the World Alzheimer Report 2016, Alzheimer’s disease affects an estimated 47 million people worldwide.
It costs healthcare systems worldwide more than US$818 billion per year and is the fifth leading cause of death in those aged 65 or older.
The Alzheimer’s Association estimates that there are more than 5 million cases in the United States alone, with a new case being identified every 66 seconds.
The annual cost to the country in 2017 is estimated have been $259 billion, with that figure predicted to potentially rise to $1.1 trillion by 2050.
Previously, the team had developed a simple saliva test that can diagnose Alzheimer’s disease, as well as predict its future onset.
The test is based on measuring the concentration of the peptide amyloid beta protein 42 (Abeta42) secreted in saliva.
In most people, the rate of Abeta 42 production is almost exactly the same regardless of sex or age.
However, if that rate of production is two to three times higher, those individuals are destined to develop Alzheimer’s disease.
That is because Abeta42 is a relatively insoluble material.
Although it is made everywhere in the body, deposits of it occur only in the brain, causing neuroinflammation, which destroys neurons in the brains of people with Alzheimer’s disease.
Contrary to the widely held belief that Abeta 42 is made only in the brain, the team demonstrated that the peptide is made in all organs of the body and is secreted in saliva from the submandibular gland.
As a result, with as little as one teaspoon of saliva, it is possible to predict whether an individual is destined to develop Alzheimer’s disease.
This gives them an opportunity to begin taking early preventive measures such as consuming non-prescription non-steroidal drugs (NSAIDs) such as ibuprofen.
Knowing that the prevalence of clinical Alzheimer’s Disease commences at age 65, the researchers recommend that people get tested ten years before, at age 55, when the onset of Alzheimer’s would typically begin.
If they exhibit elevated Abeta 42 levels then, that is the time to begin taking daily ibuprofen to ward off the disease.
The team now has a simple test that can indicate if a person is fated to develop Alzheimer’s disease long before it begins to develop.
People can prevent that from happening through a simple solution that requires no prescription or visit to a doctor.
The study is published in the prestigious Journal of Alzheimer’s Disease.
Copyright © 2018 Knowridge Science Report. All rights reserved.
Source: Journal of Alzheimer’s Disease.
